115 related articles for article (PubMed ID: 38095985)
1. Low expression of
Liang Q; Liu S; Yin F; Liu M; Wang L; Guo E; Lei L; Wu L; Yang Y; Zhang D; Zeng X
Biomark Med; 2023 Sep; 17(18):755-765. PubMed ID: 38095985
[No Abstract] [Full Text] [Related]
2. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
Sun C; Huang S; Wang H; Xie R; Zhang L; Zhou Q; He X; Ju W
Mol Carcinog; 2019 Dec; 58(12):2266-2275. PubMed ID: 31523845
[TBL] [Abstract][Full Text] [Related]
3. GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors.
Li Y; Li B; Xu Y; Qian L; Xu T; Meng G; Li H; Wang Y; Zhang L; Jiang X; Liu Q; Xie Y; Cheng C; Sun B; Yu D
Cancer Res; 2022 Sep; 82(18):3223-3235. PubMed ID: 35895805
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CASC19 contributes to tumor progression and predicts poor prognosis after radical resection in hepatocellular carcinoma.
Hou Y; Tang Y; Ma C; Yu J; Jia Y
Dig Liver Dis; 2023 Jun; 55(6):799-806. PubMed ID: 36805849
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
8. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
Yan TH; Qiu C; Sun J; Li WH
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248
[TBL] [Abstract][Full Text] [Related]
9. Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein.
Zhu Y; Cui J; Liu J; Hua W; Wei W; Sun G
Cancer Med; 2020 May; 9(10):3592-3603. PubMed ID: 32160655
[TBL] [Abstract][Full Text] [Related]
10. Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients.
Han CP; Yu YH; Wang AG; Tian Y; Zhang HT; Zheng ZM; Liu YS
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5481-5489. PubMed ID: 30229819
[TBL] [Abstract][Full Text] [Related]
11. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
[TBL] [Abstract][Full Text] [Related]
12. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma.
Li J; Wang J; Liu Z; Guo H; Wei X; Wei Q; Zheng S; Xu X
J Cancer Res Ther; 2022 Dec; 18(7):1919-1925. PubMed ID: 36647950
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.
Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q
J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591
[TBL] [Abstract][Full Text] [Related]
15. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of miR-1266-5p serves as a prognostic biomarker of hepatocellular carcinoma and facilitates tumor cell proliferation, migration and invasion.
Su Y; Xie R; Xu Q
Acta Biochim Pol; 2021 May; 68(2):293-300. PubMed ID: 34006084
[TBL] [Abstract][Full Text] [Related]
17. MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
Qu W; Wen X; Su K; Gou W
J Cell Mol Med; 2019 Feb; 23(2):1541-1552. PubMed ID: 30597727
[TBL] [Abstract][Full Text] [Related]
18. Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients.
Bai B; Lin Y; Hu J; Wang H; Li L; Zhao S; Zhang J; Meng W; Yue P; Bai Z; Li X
Oncol Rep; 2019 Mar; 41(3):1539-1548. PubMed ID: 30747220
[TBL] [Abstract][Full Text] [Related]
19. Abnormal Expression of Centromere Protein U Is Associated with Hepatocellular Cancer Progression.
Yu Y; Chen X; Zhang W; Liu J
Biomed Res Int; 2021; 2021():4051192. PubMed ID: 34957303
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
Gong J; Du C; Sun N; Xiao X; Wu H
J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]